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In this study the distribution of species and antimicrobial resistance among 
vancomycin resistant enterococci (VRE) recovered from clinical specimens ob-
tained from fi ve hospitals in Belgrade was analyzed. Strains were further character-
ized by pulsed-fi eld gel electrophoresis (PFGE). Polymerase chain reaction (PCR) 
was used to investigate the presence of vanA and vanB genes and pathogenicity 
factor genes. Identifi cation of 194 VRE isolates revealed 154 Enterococcus faecium, 
21 Enterococcus faecalis, 10 Enterococcus raffi nosus and 9 Enterococcus gallina-
rum. This study revealed existence of 8 major clones of VRE. PCR determined vanA 
gene to be present in all of the VRE studied. Esp and hyl genes were present in 
29.22% and 27.92% of E. faecium, respectively, and in 76.19% and 0 of E. faecalis, 
respectively. Esp and hyl genes were not found more frequently in members of pre-
dominant clones of E. faecium than in single isolates; nor was their presence con-
nected to invasiveness.
Keywords: vancomyc in resistant enterococci (VRE), pulsed-fi eld gel elec-
trophoresis (PFGE), pathogenicity factor genes, antimicrobial resistance
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Introduction
Enterococci are natural inhabitants of the gastrointestinal tract of humans 
and other animals. Causative agents of invasive and non-invasive infections and 
harmless commensals of the digestive and urogenital tracts of humans and mam-
mals became more dangerous and diffi cult to treat when they gained another 
feature: vancomycin resistance genes. With the emergence of vancomycin resist-
ance, treatment options for infections caused by this microorganism became nar-
rower.
Until recently, Enterococcus faecalis has been reported to be responsible 
for 80 to 90% of all clinical isolates, while Enterococcus faecium accounted for 
5 to 15%. Other Enterococcus species (Enterococcus gallinarum, Enterococcus 
casselifl avus, Enterococcus durans, Enterococcus avium, and Enterococcus raf-
fi nosus) are encountered much less frequently and account for less than 5% of 
clinical isolates [1].
Seven phenotypes of acquired vancomycin resistance have been reported 
in enterococci [2]; the most prevalent are VanA and VanB, in which the genes 
encoding resistance are associated with mobile genetic elements that allow resist-
ance to spread clonally and laterally [3]. Acquired resistance to glycopeptides 
(vanA and van B) has been reported for E. faecalis, E. faecium, E. avium, E. du-
rans, E. raffi nosus, E. gallinarum, E. casselifl avus, Enterococcus hirae and En-
terococcus mundtii [4].
In this study, we analyzed the distribution of species and antimicrobial re-
sistance among enterococci recovered from clinical specimens obtained from 
fi ve hospitals in Belgrade over a fi ve-year period. Clonal relatedness and presence 




A prospective study was conducted from January 2002 to October 2006 in 
the Bacteriology laboratory of the Clinic for Infectious and Tropical Diseases. 
The Clinic is part of the Clinical Center of Serbia (CCS), the biggest tertiary care 
institution in the country, with 3300 beds and a full range of medical specialties. 
The Bacteriology Laboratory of the Clinic for Infectious and Tropical Diseases 
process specimens predominantly for that Clinic, but also for other clinics of the 
CCS. In addition to those obtained from the CCS, the study included VRE strains 
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provided by employees at four other health institutions. All four institutions are 
located in Belgrade (Table I).
Based on source of isolation, three categories of isolates were identifi ed: 
invasive, 57 (29.38%) from blood; non-invasive, 31 (15.98%) from wounds and 
urine; and carrier, 106 (54.64%) from stool, sputum, vagina, skin, nose and phar-
yngeal swabs.
Preliminary identifi cation
Cultures were obtained within 24 hours of collection, placed on blood 
agar plates with 5% sheep blood, and incubated overnight at 35 °C. Isolates were 
identifi ed at the genus level by the bile-esculin agar test accompanied by the 
Gram-staining method and catalase test. Beginning 1 January 2005, all entero-
Table I. Distribution of Enterococcus spp. isolated from hospitalized patients, 
according to clinics and hospitals
Hospitals E. faecium E. faecalis E. raffi nosus E. gallinarum Total
Clinical Center of Serbia
  Clinic for Infectious 
and Tropical
 Diseases 34  2 2 38
 Clinic for Hematology 65  3 68
 ICU of Emergency Center 24 12 7 8 51
  Clinic for Pulmonary Diseases 
and Tuberculosis
11  1 1 13
 Clinic for Neurology  1  1
 Gynecology-Obstetrics Clinic 1  1
  Clinic for Cardio-Vascular 
Diseases
 3  3
 Neuro-Surgical Clinic  3  3
  Clinic for Ortopaedic 
and Traumatology
 1  1
Clinical Hospital Center Dedinje  8  8
Dragiša Mišović Hospital  4  4
Childrens’ University Clinic  2  2
Oncology Institute  1  1
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coccal isolates, irrespective of their clinical relevance, were screened for vanco-
mycin resistance on Vancomycin screen agar (with 6 μg/ml of vancomycin). 
 Before experimental testing, isolates were stored at –70 °C in a brain heart infu-
sion broth with 15% glycerol and cultured twice on Columbia agar supplemented 
with 5% sheep blood for 16 hours at 35 °C in an oxygen atmosphere.
Phenotypic identifi cation of Enterococcus species
Species identifi cation was determined based on tests of carbohydrate fer-
mentation, arginine hydrolysis, motility, yellow pigment production, hydrolysis 
of L-pyrrolidonyl-β-naphthylamide (PYR test), growth at 42 °C and tolerance to 
6.5% NaCl [5].
Antimicrobial susceptibilities
Antimicrobial susceptibilities were determined by the agar dilution 
method according to CLSI recommendations [6] for vancomycin, tetracy-
cline, ciprofl oxacin, linezolid, ampicillin, penicillin, chloramphenicol, nitro-
furantoin, erythromycin, gentamicin, and streptomycin. E. faecalis ATCC 
29212 was used as the reference strain. Isolates which were non-susceptible to 
three or more antimicrobials of different chemical groups were assessed as 
multidrug-resistant (MDR).
PFGE typing
Genomic DNA was prepared in agarose plugs using a previously described 
method [7], and digested with SmaI (New England Biolabs, Beverly, MA, USA). 
Pulsed-fi eld gel electrophoresis was performed for 19 hours using a CHEF-DRIII 
(Bio-Rad, Hercules, CA, USA). SmaI-digested Staphylococcus aureus NCTC 
8325 was molecular mass standard on all PFGE gels. SmaI restriction patterns 
were compared visually. Strains with identical PFGE patterns were deemed as 
parts of the clone and were considered to be the same type. Fragment patterns 
differing by one to six band differences, thus indicating closely or possibly re-
lated isolates [8], were considered subtype. To investigate the relatedness of the 
representative strains belonging to fi ve major clones, a dendrogram of each of 
them was constructed using appropriate software (Bionumerics, version 2.5, 
 Applied Maths, Kortrijik, Belgium).
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Detection of genes encoding for glycopeptide resistance
PCR experiments for detection of vancomycin resistance determinants for 
vanA and vanB genes were performed on all pulsotypes, according to the method 
of Dutka-Malen [9].
Detection of genes encoding pathogenicity factors
PCR experiments for detection of esp, cyl A, cyl B, efaAFs, efaAFm, cpd 
and cob genes were performed on all pulsotypes, using the method of Eaton and 
Gasson [10]. Multiplex PCR for asa1, gel E, hyl genes was performed using a 
previously published method [11].
Statistical analysis
The Chi-square test was used to determine if pathogenicity factor genes 
were more common in invasive or carrier members of major clones or if the genes 
could be found more frequently in clonally related than unique strains. A p value 
of <0.05 was considered statistically signifi cant (Epi Info 3.5.1 software pack-
age).
Results
Antimicrobial susceptibility testing and detection 
of vancomycin resistance genes
A total of 194 VRE were consecutively recovered during the study period. 
In 2002 and 2003 one isolate per year was documented (0.51%), followed by 6 
(3.10%) in 2004, 140 (72.17%) in 2005 and 46 (23.71%) in 2006 up until October. 
The collection consisted of 154 (79.38%) E. faecium, 21 (10.82%) E. faecalis, 10 
(5.16%) E. raffi nosus and 9 (4.64%) E. gallinarum. Numbers of isolates per insti-
tution are displayed in Table I.
All of the investigated strains were MDR. All of them uniformly harboured 
vanA gene, demonstrated by PCR, irrespective of which species was tested. 
 According to this fi nding, a high level of vancomycin resistance (≥128 μg/ml) 
was detected in all of them except for a part of E. faecalis clone c (9/12 strains) 
(Table II).
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Table II. Antimicrobial susceptibilities (in μg/ml) of the isolates studied
Antibio. Microorg.
Antibiotic concentration (μg/ml)
0.25 0.5 1 2 4 8 16 32 64 128 256 512 <512 >512 <1024 >1024
Van E. faecium 12 64  78
E. faecalis  1  3  5  2  8   2
E. raffi nosus  6   4
E. gallinarum  3   6
Tet E. faecium 49 12  1   9  1  2 12 46 16  1  4   1
E. faecalis  1  7 13
E. raffi nosus  1  3  6
E. gallinarum  7  2
Cip E. faecium  1  2  0  3 17 131
E. faecalis 14  6  1
E. raffi nosus   4  5  1
E. gallinarum  1  0  4   1  1  1   1
Lzd E. faecium  1 25 128
E. faecalis  9  12
E. raffi nosus  9   1
E. gallinarum  5   4
Pen E. faecium  1 57 41  55
E. faecalis   1  2 10  8
E. raffi nosus  5  0  5
E. gallinarum  1  3  2  3
Amp E. faecium  6  6 87 36  19
E. faecalis  1   8  5  7
E. raffi nosus  4  6
E. gallinarum   1  3  3  2
Chl E. faecium   2 76 44 31  0  1
E. faecalis  4 13  0  1  3
E. raffi nosus  7 3
E. gallinarum  3  4  0  0  2
Nit E. faecium  7  6 43 80 18
E. faecalis   1  7 10  1  2
E. raffi nosus  1  9
E. gallinarum  7  1  1
Ery E. faecium 21 133
E. faecalis 10  11
E. raffi nosus  10
E. gallinarum   9
Gen E. faecium 31 123
E. faecalis  21
E. raffi nosus  10
E. gallinarum   9
Str E. faecium 6 148
E. faecalis 1  20
E. raffi nosus  10
E. gallinarum 1   8
Antibio. = antibiotic, Microorg. = microorganism, Van = vancomycin, Tet = tetracycline, Cip = ciprofl oxacin, Lzd = linezolid, Pen = 
penicillin, Amp = ampicillin, Chl = chloramphenicol, Nit = nitrofurantoin, Ery = erythromycin, Gen = gentamicin, Str = streptomycin
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The results of antimicrobial susceptibility testing reveal the best effi cacy 
of linezolid (100%), nitrofurantoin (90.7%) and chloramphenicol (75.3%). Sensi-
tivity rates to high doses of aminoglycosides were 16% and 4.1% for gentamicin 
and streptomycin, respectively. Sensitivity rates to high doses of gentamicin were 
20.1% for E. faecium and 0 for E. faecalis.
The overall sensitivity for penicillin and ampicillin was 7.2% and 14.4%, 
respectively. All E. faecalis retained sensitivity to ampicillin, a characteristic 
shared by E. gallinarum.
PFGE
The analysis of PFGE patterns revealed 49 different PFGE types and 12 
subtypes among all of the study isolates of E. faecium. Of these, 5 PFGE types 
(clones) contained at least 14 of the isolates each; 7 types contained 2 to 7 isolates 
each, and 35 types were encountered only once. The 5 major clones of this ente-
rococcus species contained 97 out of 154 E. faecium in total (Fig. 1).
Among E. faecalis 12 members (57.1% of all E. faecalis) were typed as 
clone c while three other clones contained two or three members. Two isolates 
were unique and one clone contained two subtypes. Typing revealed only one 
clone in E. gallinarum (marked as G, with one subtype), as well as in E. raffi no-
sus (grouped as R, with 5 subtypes). Characteristics of 8 major epidemic clones, 
comprising four species of enterococci discovered in this study, are presented in 
Table III.
PCR: Pathogenicity factor genes
Esp and hyl genes were detected in 45 isolates (29.2%) and 43 isolates 
(27.9%) of the E. faecium, res pectively, and in 16 isolates (76.2%) and 0 (0%) of 
E. faecalis, respectively. Both genes were confi rmed in 8 isolates (5.2%) of 
E.  faecium (Table IV).
Within fi ve major clones of E. faecium (comprising 97 isolates), the esp or 
hyl gene was present in 38 strains (clones 20 and 24; 9/38 were invasive) while 
both genes were absent in 55 out of 59 strains (clones 1, 3 and 10; 16/59 were in-
vasive and they did not harbour esp or hyl gene). The presence of either of the 
two genes in fi ve major clones was not associated with invasiveness when inva-
sive isolates were compared with non-invasive isolates (p = 0.88).
The Chi-square test revealed that esp and hyl could not be found more fre-
quently in members of fi ve predominant clones (38/97) than in single strains 
(19/35) of E. faecium (p = 0.18). 
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Figure 1. Dendrograms of 5 major clones of E. faecium showing similarity index among representative 
isolates: a) PFGE type 1; b) PFGE type 3; c) PFGE type 10; d) PFGE type 20; e) PFGE type 24
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The majority of pathogenicity factor genes could be found in E. faecalis, 
except for the hyl gene, confi ned to E. faecium, while none of them were detected 
in E. raffi nosus or E. gallinarum (Table IV).
Discussion
This research was conducted from 2002, when the fi rst VRE in Serbia was 
identifi ed, to October 2006. Before 2004, only two VRE had been isolated in the 
Bacteriology laboratory of the Clinic for Infectious and Tropical Diseases at 
the CCS; the increasing number of these bacteria from our hospitals after that 
period is consistent with the fi nding of increasing isolation of VRE in Europe 
[12], and the introduction of a screening technique for VRE of carrier origin. The 
greatest number of VRE originated from the CCS, which is the teaching hospital 
and where seriously ill patients from all over Serbia and the surrounding states of 
ex-Yugoslavia are sent for treatment. Four species of enterococci were identifi ed 
in the CCS, while only E. faecium was found at the other health care institu-
tions. PFGE results showed different clonal distributions of 5 major clones of 
E. faecium: while type 1, 3 and 10 spread over 3, 4 and 2 hospitals, respectively, 
types 20 and 24 were found at the CCS only. The fi rst three clones (in total 59/194 
VRE) lacked both the esp and hyl genes (with exception of 4 strains), while the 
Table III. Characteristics of eight major epidemic clones
PFGE type 
(No of subtypes)
No of isolates 
(% of the whole 
collection)
No of hospitals; 
clinics of CCS
Years of isolation % from isolation 
source*
1 (0) 17 (8.76) 3; a, b, c, d 2004–2006 2, 4, 11
3 (2) 28 (14.43) 4; a, b, c, d, e 2005, 2006 14, 4, 10
10 (2) 14 (7.22) 2; b, d 2005, 2006 0, 2, 12
20 (3) 20 (10.31) 1; a, b, c 2005 1, 5, 14
24 (3) 18 (9.28) 1; a, b, c, d, e, f 2006 8, 3, 7
c (0) 12 (6.19) 1; d 2005, 2006 12, 0, 0
R (1) 10 (5.16) 1; a, c, g 2005, 2006 6, 0, 4
G (5)  9 (4.64) 1; c, d 2005, 2006 9, 0, 0
Clinics of Clinical Center of Serbia (CCS): a Clinic for Infectious and Tropical Diseases, 
b Clinic for Hematology, c Intensive Care Unit of Urgent Center, d Clinic for Pulmonary Diseases 
and Tuberculosis, e Clinic for Neurosurgery, f Neurology Clinic, g Clinic for Gynecology and Obstetrics
* Order: invasive, non-invasive, carriage. Invasive: blood; non-invasive: wounds and urine; 
carrier: stool, sputum, vagina, skin, nose and pharyngeal swabs.
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Table IV. Type specifi city, pathogenicity factor content and capability of hemolyzis on blood agar 
for four species of VRE
Type esp gel E cylB cpd cob ace efaAfs/efaAfm cylA asa1 hyl hemol
1 (17) – – – – – – + – – – –
2 (2) – – – – – – + – – – –
3 (15) – – – – – – + – – – –
3a (3) – – – – – – + – – – –
3b(10) – – – – – – + – – – –
4 (6) – – – – – – + – – + –
4a (1) – – – – – – + – – + –
5 (1) – – – – – – + – – – –
6 (1) – – – – – – + – – – –
7 (1) + – – – – – + – – + –
8 (1) – – – – – – + – – – –
9 (3) + – – – – – – – – – –
10 (10) – – – – – – + – – – –
10a (3) – – – – – – + – – + –
10b (1) + – – – – – + – – – –
11 (1) – – – – – – + – – – –
12 (1) + – – – – – + – – – –
13 (1) – – – – – – + – – + –
14 (1) + – – – – – + – – – –
15 (1) + – – – – – + – – + –
16 (1) + – – – – – + – – – –
17 (2) + – – – – – + – – + –
18 (1) – – – – – – + – – – –
19 (2) + – – – – – + – – – –
19a (1) + – – – – – + – – – –
20 (14) + – – – – – + – – – –
20a (3) + – – – – – + – – – –
20b (1) + – – – – – + – – – –
20c (2) + – – – – – + – – – –
21 (1) – – – – – – + – – – –
22 (1) – – – – – – + – – – –
23 (1) – – – – – – + – – + –
24 (13) – – – – – – + – – + –
24a (3) – – – – – – + – – + –
24c (1) – – – – – – + – – + –
24d (1) – – – – – – + – – + –
25 (3) + – – – – – + – – + –
26 (1) – – – – – – + – – + –
27 (1) – – – – – – + – – – –
28 (1) + – – – – – + – – – –
29 (1) – – – – – – + – – + –
30 (1) + – – – – – + – – – –
31 (1) + – – – – – + – – + –
32 (1) – – – – – – + – – – –
33 (1) + – – – – – + – – – –
34 (1) + – – – – – + – – – –
35 (1) – – – – – – + – – – –
36 (1) + – – – – – + – – – –
37 (1) + – – – – – + – – – –
38 (1) – – – – – – + – – – –
39 (1) – – – – – – + – – – –
40 (1) + – – – – – + – – – –
41 (1) – – – – – – + – – + –
42 (1) – – – – – – + – – + –
43 (1) – – – – – – + – – – –
44 (1) – – – – – – + – – – –
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Table IV. (cont.)
Type esp gel E cylB cpd cob ace efaAfs/efaAfm cylA asa1 hyl hemol
45 (1) – – – – – – + – – – –
47 (1) – – – – – – + – – + –
49 (2) – – – – – – + – – – –
b (1) – + – + + + + – + – –
c (12) + + – + + + + – + – –
d (1) + + + + + + + + + – –
d1 (1) + + + + + + + + + – –
d2 (1) + + + + + + + + + – –
g1 (2) – + + + + + + – + – +
h (1) + + + + + + + – + – +
m (2) – + – + – + + – + – –
R (1) – – – – – – ND – – – –
R1 (1) – – – – – – ND – – – –
R2 (2) – – – – – – ND – – – –
R3 (4) – – – – – – ND – – – –
R4 (1) – – – – – – ND – – – –
R5 (1) – – – – – – ND – – – –
G (8) – – – – – – ND – – – –
G1 (1) – – – – – – ND – – – –
Numbers in parenthseis present number of isolates belonging to that clone (type and subtype) and are 
bolded. ND = not determined. E. faecium is marked with numbers, subrype with small letters added; 
E. faecalis is marked with small letters, subtypes have numbers added; E. raffi nosus are marked with 
R and subtypes with numbers added; E. galinarum are marked with G and subtype with number added. 
Hemol = hemolysis
other two (38/194 VRE) contained either the esp or hyl gene, known to be viru-
lence elements of nosocomial enterococci that increase their ability to colonize 
hospitalized patients [13]. Finding esp or hyl genes in major clones typed as 20 
and 24 indicate that the concentration of enterococcal pathogenicity factor genes 
in VRE is found in the CCS. As expected, our study could not however prove that 
invasive isolates of fi ve major E. faecium clones contain more pathogenicity fac-
tor genes, esp and hyl, than non-invasive isolates (p ≥ 0.05). We also could not 
prove that the enterococcal surface protein gene (esp) is an important marker in 
epidemic strains, even though it is assumed that its presence seems to be limited 
to hospital-acquired E. faecium clones [14]. There was no statistical signifi cance 
in the presence of the esp or hyl genes in members of predominant clones com-
pared to single pulsotypes of E faecium.
The fi nding that 9.8% enterococci was not one of the two most frequently 
encountered enterococcus species is somewhat different from previous studies 
where such species accounted for less than 5% of VRE [1]. A high proportion 
of E. raffi nosus and E. gallinarum in our study is apparently due to their clonal 
spread in the special conditions at the Intensive Care Unit of the Emergency 
Center, which seem to have changed the percentage of enterococcus species in a 
way which rarely occurs. Although the virulence of those species is low and they 
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usually colonize the digestive tract of patients hospitalized in intensive care units, 
their capability of causing invasive infections has been previously recognized 
[15]. Vancomycin resistant E. gallinarum is known to carry the vanC gene which 
is located in a bacterial chromosome [1]. The gene cannot be transferred to other 
enterococci or other bacterial genera and is of little epidemiological relevance 
meaning that we chose not to investigate its presence in this species. On the con-
trary, VanA type of resistance is considered infectious, since the vanA gene is 
confi ned to mobile genetic elements which can easily be spread to other entero-
cocci of the same or different species, or other genera, like S. aureus. In E. raf-
fi nosus and E. gallinarum from our study, the vanA gene probably was connected 
to their clinical (invasiveness) as well as epidemiological relevance (clonal 
spread). The vanA gene, carried on transposon or plazmid, could also be gained 
by E. faecalis clone c and two clones of E. faecium, which were also detected in 
strains originating from patients in the Intensive Care Unit of the Emergency 
Center.
Ampicillin has proven to be the drug of choice for E. faecalis in our study, 
and also effective for E. gallinarum [16]. To achieve the bactericidal effect, in 
severe enterococcal diseases, combined therapy with penicillin and aminoglyco-
side antibiotics is recommended. Even strains with lower levels of ampicillin re-
sistance (MICs ≤64 μg/ml) may still respond to a combination of therapy with 
ampicillin and an aminoglycoside, as long as the isolate does not demonstrate 
high-level resistance to the aminoglycoside co-drug [16]. In consideration with 
this, aminoglycoside therapy for all non-E. faecium from our study could be com-
bined with ampicillin, for strains sensitive to high level dozes of gentamicin or 
streptomycin. Unfortunately, the percentage of high level gentamicin resistant 
(HLG) enterococci was high: 79.8% and 100% for E. faecium and E. faecalis re-
spectively, compared to overall HLG resistance in Europe of 39.3% and 32.9% for 
E. faecium and E. faecalis, respectively [17]. The data provided by EARSS, 
though, refers to all vancomycin sensitive and resistant enterococci, while in 
this study only VRE were tested. Still, our HLG resistance rates, especially for 
E. faecalis are much bigger compared to those obtained by EARSS, when we take 
into account that the aminoglycoside resistance rate in VRE is two times higher 
than in vancomycin sensitive enterococci [18]. 
In conclusion, we have found genetically related clusters of strains from 
different hospitals, clusters that appeared in single institutions within the CCS, 
and strains of unique pulsotypes. The VRE in the present study were highly re-
sistant to vancomycin, penicillins and ciprofl oxacin, while their resistance to 
aminoglycisodes is cause for concern. Stringent epidemiological measures to 
stop clonal spreading of VRE within the CCS are warranted, as well as restricted 
use of broadspectrum antibiotics.
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